Assessing Human Embryonic Stem Cell-Derived Dopaminergic Neuron Progenitor Transplants Using Non-invasive Imaging...

Area of Science:

• Neuroscience
• Regenerative Medicine
• Biomedical Imaging

Background:

• Human pluripotent stem cell-derived dopaminergic progenitor cells (hPSC-DAPCs) offer a potential Parkinson's disease (PD) therapy.
• Intracranial transplantation of these cells raises safety concerns regarding proliferation, migration, and inflammation.

Purpose of the Study:

• To investigate the in vivo fate and safety of hPSC-DAPC transplants in the rat striatum using a bimodal imaging approach.
• To assess the long-term engraftment and differentiation of transplanted cells.

Main Methods:

• hPSC-DAPCs were labeled with luciferase/ZsGreen or MPIOs and transplanted into the rat striatum.
• In vivo tracking was performed using bioluminescence imaging and magnetic resonance (MR) imaging.
• Post-mortem histological analysis was conducted to evaluate cell differentiation and glial reactivity.

Main Results:

• Bioluminescence signal attenuated by week 2, but MR imaging showed MPIO-labeled DAPCs remained at the injection site for over 120 days.
• Histological analysis confirmed that cell labeling did not impede differentiation into mature dopaminergic neurons.
• No increased glial reactivity was observed in labeled cells compared to controls.

Conclusions:

• The study supports the safety of transplanting hPSC-derived DAPCs for Parkinson's disease treatment.
• Bimodal imaging effectively tracked cell survival and integration.
• Labeled cells demonstrated appropriate differentiation and integration without adverse inflammatory responses.